当前位置:首页 - 行情中心 - 第一医药(600833) - 财务分析 - 利润表

第一医药

(600833)

  

流通市值:25.10亿  总市值:25.10亿
流通股本:2.23亿   总股本:2.23亿

利润表

报告期2023-12-312023-09-302023-06-302023-03-31
公司类型通用通用通用通用
一、营业总收入1,819,516,165.791,335,807,678.27898,243,966.18459,099,405.27
营业收入1,819,516,165.791,335,807,678.27898,243,966.18459,099,405.27
二、营业总成本1,791,998,507.541,307,287,990.97873,681,466.03449,236,452.47
营业成本1,471,961,833.611,083,870,255.77728,545,960.58372,152,329.58
税金及附加8,358,562.163,919,891.472,856,847.721,860,116.32
销售费用239,312,154.08169,173,315.96110,196,401.0558,953,869.68
管理费用77,920,239.455,923,634.6137,730,400.1916,398,932.48
财务费用-5,554,281.71-5,599,106.84-5,648,143.51-128,795.59
其中:利息费用7,588,182.556,711,313.175,517,204.082,831,195.57
其中:利息收入13,583,712.2412,419,703.7610,667,354.263,147,049.35
加:公允价值变动收益12,137,397.266,820,000374,000-
加:投资收益11,726,371.25,363,884.954,744,941.11-
资产处置收益65,128,680.613,952,443.24909,624.131,120,533.46
资产减值损失(新)-5,650,044.12---
信用减值损失(新)-12,360,247.13193,128.62193,128.62-
其他收益454,413.563,037,954.432,243,183.682,148,425.5
营业利润平衡项目0000
四、营业利润98,954,229.6347,887,098.5433,027,377.6913,131,911.76
加:营业外收入19,881,711.3527,596,685.0326,795,989.9725,817,244.55
减:营业外支出1,325,249.56600,984.64488,701.29102,312.46
利润总额平衡项目0000
五、利润总额117,510,691.4274,882,798.9359,334,666.3738,846,843.85
减:所得税费用28,235,457.4217,382,022.7913,505,071.619,233,909.05
六、净利润89,275,23457,500,776.1445,829,594.7629,612,934.8
持续经营净利润89,275,23457,500,776.1445,829,594.7629,612,934.8
归属于母公司股东的净利润89,275,23457,500,776.1445,829,594.7629,612,934.8
(一)基本每股收益0.40.260.210.13
(二)稀释每股收益0.40.260.210.13
八、其他综合收益4,001,955.9134,380,811.7750,882,467.9814,231,350.22
归属于母公司股东的其他综合收益4,001,955.9134,380,811.7750,882,467.9814,231,350.22
九、综合收益总额93,277,189.9191,881,587.9196,712,062.7443,844,285.02
归属于母公司股东的综合收益总额93,277,189.9191,881,587.9196,712,062.7443,844,285.02
公告日期2024-03-302023-10-282023-08-312023-04-29
审计意见(境内)标准无保留意见
TOP↑